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Background : Atherosclerosis is the pivotal role in cardiovascular disease (CVD) involving oxidative stress dan 
inflammation. Garcia Mangostana has been proven to have an antioxidant property for years; however, the 
application of this compound in the case of atherosclerosis has not been performed. 
Objectives : This study was performed to explore the role of α-Mangostin of Garcia Mangostana Pericarp Extract 
as an antioxidant to inhibit atherosclerotic process in patients with high-risk Framingham score.
Methods : This prospective cohort study was conducted in patients with high-risk Framingham score. The patients 
were divided into two groups. The first group was administered  2520 mg/day of Garcinia mangostana Linn 
extracts (GMLE) in 3 divided doses for 90 days. The second group was administered a placebo. The outcome 
measures in our study were Nitric Oxide (NO), Superoxide Dismutase (SOD), and Malondialdehyde (MDA). They 
were measured at baseline and 90 days after treatment. The independent T-test was performed to assess the 
homogeneity of data, and the multiple logistic regression was used to assess the association.
Results: Among the 77 subjects, we found that the plasma MDA concentration was significantly decreased 
compared with placebo 0,29±0.5 vs -0.04±0.25, respectively p = 0.011). SOD level significantly decreased in 
GMLE patients compared with placebo (0,17±0.79 vs -0.27±0.67, respectively, p=0.010) and we found that 
there was slightly increased of nitric oxide (NO), but no significantly compared with placebo 4.34±10.01 and 
2.35±7.39, respectively, p = 0.37).
Conclusion: Garcinia mangostana pericarp extract has an antioxidant effect that significantly inhibits atherosclero-






 Cardiovascular disease (CVD) is a general term for heart and 
blood vessel disease.1 Cardiovascular disease is the primary cause of 
death worldwide, with more than 17.3 million death annually in 2013, 
and predicted to grow more than 23.6 million in 2030.2 Among them, 
7.4 million death were estimated caused by coronary heart disease and 
6.7 million by stroke.3 Coronary heart disease manifests the atheroscle-
rosis process and may involve many pathologic processes, including 
chronic inflammation, endothelial dysfunction, and lipid accumula-
tion.4
 Chronic inflammation in atherosclerosis was occurred by 
lipid accumulation and intracellular formation of reactive oxygen 
species (ROS). On physiological conditions, there is a balance between 
the formation of oxygen free radical and antioxidant mechanisms.5 
One of the natural  antioxidant substances is superoxide dismutase 
(SOD) in whichcatalyzing superoxide anion to form hydrogen 
peroxide.6 The increase of ROS, in turn, would lead to endothelial 
dysfunction, as indicated by the level of nitric oxide (NO)7 and circulat-
ing endothelial cells (CEC). Therefore, the discovery of the antioxidant 
agent has a critical role in reversing the mechanism, lowering oxidative 
stress, and preventing atherosclerosis process.8
 MDA is a profoundly responsive compound which is the last 
result of lipid peroxidation and is typically utilized as a biological lipid 
peroxidation biomarker to assess oxidative stress. Free radicals have a 
very short half-life that is difficult to measure in a laboratory. Lipid 
tissue damage due to ROS can be assessed by measuring the MDA 
compounds, in which they are lipid peroxidation products.
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the potency as the antioxidant agent. Mangosteen is frequently used in 
many Asian countries as traditional medicine for healing wounds, 
antimicrobial in dysentery, and eczema. Several studies have been 
conducted to investigate mangosteen potency, which has active metab-
olite xanthone, antioxidant properties. Fifty xanthone derivates could 
be extracted from pericarp of mangosteen, and the principal constituent 
is α-mangosteen. 9
 The previous study had proven the pericarp extract of Garcin-
ia mangostana as an effective antioxidant and anti-inflammation in 
atherosclerotic rats after five weeks of treatment.10 Another previous 
study for the toxicity of pericarp extract of Garcinia mangostana in 
animal models had shown no toxic effect in blood tests and internal 
organs, including liver and kidney.11 Therefore, our study aimed to 
assess the potency of pericarp extract of Garcinia mangostana as an 
antioxidant in high-risk Framingham Score patients
2. Methods
2.1. Study Design and Patient 
 A prospective cohort study was conducted at the Cardiology 
outpatient clinic at Saiful Anwar General Hospital Malang, Indonesian 
Heart Association and geriatric association in Malang, Indonesia. All 
patients with high-risk Framingham Score (score more than 14 for a 
male patient and 17 for female) were included in our study. Patients 
with the following criteria: increased transaminase, renal failure, 
prolonged coagulation, history of Non-Steroid Anti Inflammation drugs 
(NSAID) consumption, history of Cerebrovascular Attack (CVA), 
history of drug allergic, heart failure NYHA III-IV, and history of narcot-
ics consumption were excluded from our study. Subsequently, patients 
who died and who did not complete follow-up were classified into 
drop-out criteria. The information related to the risk, benefit and 
purpose of our study was provided to patients before the study. All 
patients had provided written informed consent. The Ethical Commit-
tee had approved our Faculty of Medicine study protocols, Brawijaya 
University, Malang Indonesia (no. 64/EC/KEPK/03/2018).
2.2. Laboratory Parameters
 The laboratory parameters in our present study were the 
levels of MDA, SOD, and NO. All laboratory parameters were 
performed in Biomedical and Physiological laboratory of Brawijaya 
University and Pattimura® laboratory. Our study's laboratory parame-
ters were performed before and after the administration of Garcinia 
mangostana L  for three months.  
2.3. Garcinia Mangostana Linn Extract
 Garcinia mangostana Linn extract was supplied by Zena 
Nirmala Sentosa (Garcia) company in Bogor. Each capsule contains 
420 mg extract of Garcinia mangostana L. The patients were given 
Garcia 2520 mg/day in 6 divided doses for 90 days.
2.4. Statistics
 All data were presented in mean ± standard deviation (SD). 
A paired T-test was used to perform statistical analysis for the paramet-
ric data. If data were not homogenous, the Mann Whitney and Wilcox-
on rank test was used. For subgroup analysis, we used one-way 
ANOVA. All data were analyzed by SPSS version 22 (SPSS Inc). P-value 
<0.05 was considered statistically significant. 
3. Results
3.1. Subject characteristics
 Patients were divided into two groups. The first group 
received GMLE, and the second group received placebo in addition to 
statin and a combination of several drugs (ACE inhibitors/ ARB or Oral 
antidiabetic). Blood samples were obtained from patients before and 
after received GMLE and placebo for 90 days. All of the baseline charac-
teristics were homogenous between groups (p>0.05) (Table 1).
3.2. Comparison of antioxidant parameters between groups
 After administering Garcia Mangostana Pericarp Extract 
therapy for three months, a significant change in MDA levels was 
observed between the treatment groups compared to the controls 
(-0.29 ± 0.5 and -0.04 ± 0.25, respectively P = 0.011). The levels of 
SOD was significantly higher in the treatment group compared to the 
placebo (0.17 ± 0.79 and -0.27 ± 0.67, respectively P = 0.010). 
However, the levels of NO between the treatment and control groups 
were similar (4.34 ± 10.01 and 2.35 ± 7.39, respectively P = 0.37, 
respectively (figure1). 
3.3 Sub-group analysis
 In the sub-group analysis, in the combination of high-intensi-
ty statins and Garcinia Mangostana Linn extract, lower MDA levels were 
found in the treatment group compared to placebo. The summary of our 

























































































Tabel 1. Baseline characteristics of the patients.
Note; BMI, Body Mass Index BP, blood pressure; HDL, high-density lipopro-
tein; LDL, low-density lip-oprotein; bpm, beats per minute; IL-1, interleukin-1; 
IL-6, interleukin-6; SOD, Superoxide Dismutase; MDA, Malondialdehyde. 
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Table 2. Summary of the findings in our study.
Note; SOD, Superoxide Dismutase; MDA, Malondialdehyde; DMLE, Garcinia 
mangostana Linn extracts  
4. Discussion
 This investigation was conducted to demonstrate the use of 
Garcinia mangostana Linn pericarp extract as an antioxidant agent in 
high-risk patients according to the Framingham score. Atherosclerosis is 
a chronic and progressive disease, caused by various molecular 
activities, leading to structural disruption and vascular homeostasis. 
The atherosclerosis was caused by dyslipidemia, chronic inflammation, 
free radical production, and endothelial dysfunction.12 This study was 
mainly focused on the role of free radicals and endothelial dysfunction, 
leading to direct implications of building up atherosclerotic plaque. The 
association between Garcia Mangostana Pericarp Extract and athero-
sclerosis was investigated by measuring SOD, MDA, and NO levels. 
 Pathogenesis of atherosclerosis in endothelial dysfunction 
caused by ox-LDL is through the activation of lectin-like ox-LDL 
receptors (LOX-1).13 LOX-1 is an ox-LDL receptor in endothelial cells. 
Ox-LDL may bound to LOX-1 to enter the cell and induce ROS forma-
tion. Excessive formation of ROS may trigger the emergence of MDA as 
a result of lipid peroxidation. Endogenous antioxidants, one of them is 
SOD, will respond to the emergence of MDA. This imbalance levels 
between MDA and SOD may increase free radicals, which may worsen 
the atherogenesis state.
 The observation was carried out for 90 days on Garcia 
Mangostana Pericarp Extract's administration, and the following results 
were obtained: by administering Garcia Mangostana Pericarp Extract at 
a dose of 2520 mg/day there was a decrease in MDA levels, increased 
levels of SOD and NO levels. Our study's findings supported the results 
of previous studies evaluating the activity of Garcia Mangostana 
Pericarp Extract as an antioxidant. They showed that Garcia Mangosta-
na Pericarp Extract significantly reduced intracellular ROS production 
measured using 2,7-dichlorofluorescein diacetate (DCFH-DA) SKRBR 
cells.14 In our study, the antioxidant activity was measured using SOD 
and MDA as parameters of free radicals. 
 The SOD enzyme parameters were used to elucidate the 
antioxidant effect of Garcia Mangostana Pericarp Extract. In our study, 
there is a meaningful differentiation between the SOD levels of the 
Garcia Mangostana Pericarp Extract group patients compared to the 
placebo group patients, with a p-value = 0.010. SOD levels increased in 
the treatment group, and vice versa decreased in the placebo group. 
 The conditions of high free radicals are frequently causing 
interference with SOD formation, especially in MnSOD and EC SOD. 
MnSOD is formed in the mitochondria, which require mitochondrial 
import machines to circulate in the cytosol and carry out their 
functions. In high conditions, free radical can reduce the level of cytoso-
lic MnSOD. Besides, SOD scavenges metabolites, defined as H2O2, can 
also reduce the amount of functional SOD2 protein, although it does 
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not affect mRNA expression from SOD2.15 The results in this study are 
consistent with previous studies from Wang et al., 2015 which reported 
that xanthones from Garcinia mangostana increased the levels of 
antioxidant enzymes, such as SOD and GSH.16
 Oxidized LDL is the initial stage of atherosclerosis. Free 
radicals are atoms or molecules that contain unpaired electrons, and 
are unstable and may trigger the damage cells by taking one hydrogen 
atom from other molecules of the body.17 Free radicals are found in the 
body through daily metabolism and will soon be converted into 
substances that are not harmful to the body, namely H2O and CO2. 
However, if free radicals exceed the antioxidant protection limit and 
then meet with polyunsaturated fatty acids, lipid peroxidation may 
occur, a chain reaction of lipid oxidation by free radicals. Lipid peroxi-
dation reaction will eventually produce aldehyde compounds, one of 
which is MDA, commonly used as a biological biomarker of lipid peroxi-
dation and describes the degree of oxidative stress. To prevent lipid 
peroxidation, antioxidants are needed to stabilize free radicals not to be 
harmful to the body.18
 
 This study found that lower MDA levels in patients in the 
Garcia Mangostana Pericarp Extract extract group were observed 
compared to placebo, with p = 0.011. The results of this study are 
consistent with the previous study. They reported that Garcia Mangos-
tana Pericarp Extract could reduce MDA levels, derived from xanthones' 
effects as antioxidants that inhibit lipid peroxidation. 19
 Homeostasis between antioxidants and free radicals 
determines vascular endothelial cells' function, which may produce NO 
mediators. NO is produced by vascular endothelial cells, via the 
NO-synthase (NOS) enzyme, from the L-arginine substrate and oxygen. 
NO has various roles in vascular, counting guidelines of vascular tone 
and restrains platelet aggregation and vascular smooth muscle cell 
proliferation. In atherosclerotic conditions, this function is disrupted by 
high levels of free radicals, such as O2- which react NO to form 
peroxynitrites (ONOO-.20 In this study, there was an increase in NO 
levels, but not significantly in the Garcia Mangostana Pericarp Extract 
group patients, with p = 0.37. This study's results are slightly different 
from previous studies where there was a significant increase in NO 
levels. This increase in NO levels may come from the effect of xanthones 
that inhibit the activity of iNOS, whose activity is induced by inflamma-
tion and free radicals and will activate eNOS.21 The insignificant 
findings in our study might be caused by the potency of bias, either 
from the study period or the small sample size.
5. Conclusion
 Garcinia mangostana Linn pericarp is proven to inhibit the 
atherosclerosis process through free radical scavenging and endotheli-
al function improvement.
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